Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kalium Muriaticum (also known as Kali Muriaticum or Kali Mur) is a homeopathic remedy whose active ingredient is potassium chloride (KCl). It is one of the 12 Schuessler biochemic tissue salts, introduced into homeopathic practice by Wilhelm Schüssler, and is prepared through the homeopathic process of potentization. In clinical research, it has been evaluated as a component of a homeopathic combination product—alongside Agraphis nutans, Thuya occidentalis, and Arsenicum iodatum—as an adjuvant to standard aerosol therapy (ambroxol and budesonide) in children with otitis media with effusion (secretory otitis or 'glue ear'). Traditionally, Kalium Muriaticum is indicated for catarrhal and inflammatory conditions, particularly of the ears, nose, and throat, including ear infections, eustachian tube congestion, and nasal congestion with white discharge. As a homeopathic preparation, it has no known specific biological target in the conventional pharmacological sense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kalium muriaticum.